News

For all media inquiries please call 210-396-5008 or click here.

Mylan Completes Acquisition of Renaissance’s Leading Topicals-Focused Specialty and Generics Business

ERTFORDSHIRE, England and PITTSBURGH, June 15, 2016 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) today announced that it has successfully completed the acquisition of the non-sterile, topicals-focused specialty and generics business (the “Business”) of Renaissance Acquisition Holdings, LLC (“Renaissance”). The Business brings Mylan an attractive and complementary […]

Read more

Mylan to Acquire Renaissance’s Leading Topicals-Focused Specialty and Generics Business

Transaction Immediately Accretive to Adjusted Diluted EPS HERTFORDSHIRE, England and PITTSBURGH – May 13, 2016 – Mylan N.V. (NASDAQ, TASE: MYL) today announced an agreement to acquire the non-sterile, topicals-focused specialty and generics business (the “Business”) of Renaissance Acquisition Holdings, LLC (“Renaissance”) for $950 million in cash […]

Read more

DPT Serialization Capabilities Highlighted in TraceLink Webinar

Deadlines requiring unit-level traceability for all dispensers of pharmaceutical products are fast approaching. In this important webinar, TraceLink names DPT as one of the few contract pharmaceutical manufacturing resources that is ready to serialize before the US deadline. The webinar features the top serialization program managers from […]

Read more

DPT and Confab Complete $10 Million Capital Investment in San Antonio and Montreal

(San Antonio, March 8, 2016) — DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms, and Confab, a DPT company specializing in complex solids, semi-solids and liquids, have completed a combined $10 million capital investment demonstrating their commitment to continuous […]

Read more

DPT Laboratories to Offer Expertise on Topical Semi-solid Formulations at AAPS Seminar

DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solids and liquids, will be participating in a seminar with BASF at the 2015 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Orlando, Fla. The session, “The Role of Topical Semi-solid Microstructure in Formulation Performance […]

Read more

DPT Enhances Flexibility and Efficiencies at San Antonio Facility

DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solids and liquids, has implemented a new order execution strategy that will enhance operations at its San Antonio facility. The new strategy entails a realignment and augmentation of resources to support three critical areas at DPT: […]

Read more

DPT Laboratories Wins Three CMO Leadership Awards

DPT Laboratories has won three CMO Leadership Awards presented by Life Science Leader. The awards, which were announced in the March issue of Life Science Leader Magazine, are based in part on peer feedback. DPT was honored for reliability, productivity and innovation. Read the magazine.

Read more

DPT scientists present their Scientific Poster, “The Effect of Vial Stopper Height on the Plumes of Unit-Dose Nasal Sprays” at AAPS 2014

Charles Shaw and Maria Smith presented the scientific poster “The Effect of Vial Stopper Height on the Plumes of Unit-Dose Nasal Sprays” at AAPS 2014. The poster was featured by Contract Pharma. As part of a quality by design (QbD) study, the criticality of the stopper position […]

Read more

DPT Enhances Capabilities with New High-Speed Filling Center at its San Antonio Center of Excellence

DPT Laboratories, a Contract Development and Manufacturing Organization (CDMO) specializing in semi-solid and liquid dosage forms, announces the implementation of a high-speed bottle filling center at its San Antonio location. One of three DPT Centers of Excellence, the San Antonio location is purpose-built for semi-solids and liquids […]

Read more

DPT Laboratories Acquires Meda Pharmaceuticals’ Lakewood, New Jersey, Location

(San Antonio, TX) — DPT Laboratories, a contract development and manufacturing organization (CDMO) with a specialized focus on semi-solid and liquid dosage forms, announces the acquisition of Meda Pharmaceuticals’ Lakewood, New Jersey, facilities. The acquisition reflects the organization’s recent growth, allowing DPT to expand its footprint in Lakewood […]

Read more